                         SEQUENCE LISTING

<110>  MCMASTER UNIVERSITY
 
<120>  ANTIBODY RECRUITMENT MOLECULES AND METHODS OF TREATING COVID-19 
       USING SAME

<130>  41942-0007

<140>  PCT/CA2022/050262
<141>  2022-02-24

<150>  US 63/153,551
<151>  2021-02-25

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ACE2 Helix Domain Peptide

<400>  1

Ile Glu Glu Gln Ala Lys Thr Phe Leu Asp Lys Phe Asn His Glu Ala 
1               5                   10                  15      


Glu Asp Leu Phe Tyr Gln Ser 
            20              


<210>  2
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Novel Rullo S1 Binding Peptide

<400>  2

Thr Asp Glu Tyr Pro His Leu Ser Trp Ser Asp Phe Leu Tyr 
1               5                   10                  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Screen Peptide

<400>  3

Thr Val Phe Gly Leu Asn Val Trp Lys Arg Tyr Ser Lys Gly Lys 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Covalent Screen Peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Aryl-Sulfonyl Fluoride

<400>  4

Thr Val Phe Gly Leu Asn Val Trp Lys Arg Tyr Ser Lys Gly Lys 
1               5                   10                  15  


<210>  5
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope of HSV gD

<400>  5

Leu Lys Met Ala Asp Pro Asn Arg Phe Arg Gly Lys Asp Leu 
1               5                   10                  


